Really amazing . . . you guys are funny.
This has been said for years, and years, and years and years, and it's simply not true. They post regardless. I agree, they probably ARE paid. But they will keep posting, without response, here and elsewhere. This gets them off their stride. There are easy answers to their stupid points, and then they know they need to address those points, which gets them further and further away from the point that they are trying to make, which is nonsense anyway. It just brings out the fact that they have no clue and no capacity for analysis.
Institutions don't read basher lies. . . so they probably think it's cute. Keep goin'!
Bashers giving free shares to institutional investors with short positions. So nice! I'm sure they are grateful.
Oh well. You win some and you lose some!
Anyone figure out his connection yet, other than this introduction?
Good question. Seems something very good could still be pending from the EMA.
Really impressive results, 17 out of 18 and ZERO had complications caused by the cells. Same as the animal trials on that note, which also had ZERO complications caused by the cells. And the Asian results, are the SAME also, by Cha Biotech, leading to a continuing affirmation of this treatment as being a potentially smashing success. And we don't have the EU results yet, but the EMA has given them pivotal status for their Phase II, which are now, as a pivotal trial, the equivalent of a Phase III trial... pre-approval, if the EMA has not already determined to provide them with conditional marketing authority based upon their ORPHAN status. Wall Street can't let these results get away and in the hands of other investors, when it runs. So institutions are starting to accumulate, but trying to do so without causing a run just by dint of their own purchases.
The institutional interest alone, repudiates their constant thoughts. It's a losing battle. Institutions don't listen to bashers. LOL.
The list keeps growing, on a daily basis it seems.
I'm excited by the various numbers out there, including on Seeking Alpha.
Platelet Biogenesis and Ocata . . . very exciting. Waiting to hear more about the financing.
That was probably a short trying to set the price movement for the day. Oh well . . . someone is maybe under water now . . . wait it out and see what happens.